Liver injury following SARS-CoV-2 vaccination: A multicenter case series

J Hepatol. 2022 Jan;76(1):211-214. doi: 10.1016/j.jhep.2021.07.024. Epub 2021 Jul 31.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • 2019-nCoV Vaccine mRNA-1273* / administration & dosage
  • 2019-nCoV Vaccine mRNA-1273* / adverse effects
  • BNT162 Vaccine* / administration & dosage
  • BNT162 Vaccine* / adverse effects
  • Biopsy / methods
  • Biopsy / statistics & numerical data
  • COVID-19 Vaccines / administration & dosage
  • COVID-19 Vaccines / adverse effects
  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Chemical and Drug Induced Liver Injury* / blood
  • Chemical and Drug Induced Liver Injury* / diagnosis
  • Chemical and Drug Induced Liver Injury* / epidemiology
  • Chemical and Drug Induced Liver Injury* / prevention & control
  • Cholangiopancreatography, Endoscopic Retrograde / methods
  • Cholangiopancreatography, Endoscopic Retrograde / statistics & numerical data
  • Cohort Studies
  • Female
  • Humans
  • Liver Function Tests / methods
  • Male
  • Middle Aged
  • Pharmacovigilance
  • Risk Adjustment / methods*
  • SARS-CoV-2
  • Time Factors

Substances

  • COVID-19 Vaccines
  • 2019-nCoV Vaccine mRNA-1273
  • BNT162 Vaccine